Skip to main content
Assets
Aehr Test Systems logo
AEHR.NASDAQ
Aehr Test Systems
Information Technology · Semiconductor Materials & Equipment

Semiconductor test equipment company supplying wafer-level burn-in and test systems for silicon carbide, sensors, and photonics.

HQ: United StatesListed: United States

Historical AI Consensus

Audit every published iPulse AI forecast batch and immutable historical research document for Aehr Test Systems.

Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol
AEHR.NASDAQ
Batch
7
Published
September 20, 2026
AI Advisors
14

Historical AI Consensus Investment Thesis

Aehr Test Systems (AEHR) Stock Forecast and AI Rating

Deep analysis published Original pricing snapshot 12 min read
Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

PARTIAL SELL

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

SELL ALL

$61

-35.2%
2031

5-Year

PARTIAL SELL

$54

-42.5%

Published batch insight

Capital Equipment Valuation Reality Collides With Accelerating Artificial Intelligence Burn In

There is sharp divergence between accelerating artificial intelligence burn-in backlogs and long-term equity returns. High consensus identifies extreme multiple compression as the primary headwind, while lead-customer procurement lumpiness represents the decisive operational risk over the five-year investment horizon.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

Machiavelli (Insider) advisor portraitJ.P. Morgan (Titan) advisor portraitUniversal Investor (Polymath) advisor portraitWarren Buffett (Value Purist) advisor portraitElon Musk (Visionary) advisor portraitMichael Burry (Vulture) advisor portraitRay Dalio (Strategist) advisor portraitSuperintelligence (Anthropologist) advisor portraitSherlock Holmes (Whistleblower) advisor portrait

Machiavelli (Insider), J.P. Morgan (Titan), Universal Investor (Polymath), Warren Buffett (Value Purist), Elon Musk (Visionary), Michael Burry (Vulture), Ray Dalio (Strategist), Superintelligence (Anthropologist), Sherlock Holmes (Whistleblower). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models
Gemini AI model logoGeminiClaude AI model logoClaudeChatGPT AI model logoChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in Aehr Test Systems at the forecast anchor (2026-09-18): $5,745 in five years versus $13,892 for S&P 500 benchmark.

Five-year synthesized consensus forecast for Aehr Test SystemsThe diagram shows the synthesized consensus value path for Aehr Test Systems, forecast milestones, and a comparison with S&P 500 benchmark. excluding any dividend yield adjustment.$5,000$10,000$15,000$20,000$5,745 (-42.5%)$13,892 (+38.9%)Anchor2026-09-182027(1Y)2028(2Y)2029(3Y)2030(4Y)2031(5Y)
Aehr Test Systems · Synthesized ConsensusS&P 500 benchmark
Figure: Five-year synthesized consensus value path for Aehr Test Systems compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each step

Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 93.49 USD1-year price return: -35.18%5-year price return: -42.55%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in USD, with returns and rationale
QuarterTarget (USD)Quarter returnTotal returnForecast rationale
Q4 202683.28-10.92%-10.92%Initial shipments against the AI processor backlog lift quarterly revenue, but elevated Treasury yields and macroeconomic multiple compression across high-valuation technology equities spark institutional profit-taking after the parabolic summer rally.
Q1 202775.79-8.99%-18.93%Volume deliveries of high-power test systems to lead Taiwanese and networking accounts generate sequential revenue growth. However, operating expense expansion and customer concentration concerns temper investor enthusiasm, keeping share price gains muted.
Q2 202769.58-8.19%-25.57%Fiscal 2027 concludes with revenue approaching guided levels, yet gross margins below peak historical highs remind investors of hardware integration costs, prompting a sell-the-news reaction as subsequent annual comparisons stiffen.
Q3 202760.60-12.90%-35.18%Book-to-bill ratios moderate toward parity as anchor customers complete initial burn-in capacity buildouts. With secondary cluster orders entering qualification delays, sell-side analysts temper forward multiples, accelerating valuation contraction.
Q4 202755.31-8.74%-40.84%A post-expansion equipment digestion lull deepens as tool shipments outpace new bookings. Enterprise scrutiny of artificial intelligence infrastructure spending leads to selective order pushouts, extending the multiple derating across specialized equipment peers.
Q1 202851.31-7.23%-45.12%System revenue contracts sequentially while proprietary consumable contactor reorders establish an operational cash flow baseline. The equity continues adjusting downward toward normalized capital goods valuation multiples amid high interest rates.
Q2 202848.74-5.01%-47.87%Fiscal 2028 financial results confirm moderate top-line expansion but falling short of hyper-growth projections. Operating income remains positive, yet valuation multiples compress toward twenty-five times normalized earnings as speculative premiums unwind.
Q3 202846.72-4.13%-50.02%Cyclical moderation across semiconductor capital spending pauses discretionary tool additions. A net-cash balance sheet devoid of funded debt prevents financial distress, establishing fundamental asset support and arresting aggressive liquidation.
Q4 202845.32-3.01%-51.53%Valuation reaches mid-cycle equilibrium as trading multiples stabilize around historical equipment norms. Steady replacement demand for high-margin contactors buffers gross margins, providing fundamental resilience against seasonal order softness.
Q1 202945.46+0.33%-51.37%Qualification of next-generation optical transceivers and high-density computing chiplets generates fresh evaluation orders. Rebounding book-to-bill indicators attract value-oriented technology investors to a derisked equity base, generating a modest price recovery.
Q2 202947.06+3.52%-49.66%Fiscal 2029 closes with revenue stabilizing near sustainable baseline levels. Expanding consumable contactor sales lift consolidated gross margins above forty percent, confirming durable cash generation from the enlarged global installed tool base.
Q3 202947.00-0.13%-49.73%Commercial volume scaling of co-packaged optics across hyperscale datacenters drives follow-on multi-system orders. Operating leverage re-emerges as fixed manufacturing overhead is absorbed, supporting steady, earnings-driven share price appreciation.
Q4 202948.15+2.44%-48.50%Easing monetary conditions and stabilizing semiconductor fab budgets support capital expenditures. Execution against renewed backlogs produces clean operating earnings beats, reinforcing confidence in the company's specialized niche market defensibility.
Q1 203048.73+1.21%-47.87%Broader adoption of wide-bandgap semiconductors in datacenter power supplies complements optical screening demand. Customer diversification improves, mitigating single-client revenue lumpiness and supporting measured valuation multiple expansion on realized earnings.
Q2 203050.06+2.72%-46.46%Fiscal 2030 disclosures highlight record consumable shipments and double-digit operating margins. The market prices the enterprise as an established specialty semiconductor equipment supplier rather than a speculative artificial intelligence proxy.
Q3 203050.17+0.22%-46.34%Routine customer inventory rebalancing and tool maintenance cycles cause slight quarterly booking deceleration. The shares exhibit lower volatility, tracking underlying industrial capital equipment earnings rather than speculative narrative shifts.
Q4 203051.06+1.77%-45.39%Predictable recurring cash flow from proprietary contactors enables management to fund organic research and development while maintaining substantial surplus liquidity. Steady fundamentals anchor share valuation within a stable, defensible trading range.
Q1 203151.85+1.55%-44.54%Fleet upgrades for aging silicon carbide and optical test systems drive incremental hardware placements. Operating leverage remains healthy, rewarding patient shareholders with consistent book value compounding and resilient cash conversion.
Q2 203152.77+1.78%-43.56%Fiscal 2031 concludes with strong cash generation and expanding return on invested capital. Matured product lines across AI interconnects and power semiconductors validate the multi-segment testing thesis on solid fundamentals.
Q3 203153.71+1.79%-42.55%Terminal valuation achieves sustainable equilibrium at realistic capital equipment multiples of normalized operating earnings. Speculative froth has fully deflated, leaving equity valuation firmly aligned with demonstrable cash-flow generation.

Aehr Test Systems presents a classic capital equipment disconnect where commercial qualification success fails to translate into proportional equity returns. Backlog expansion to over one hundred million dollars confirms accelerating adoption of wafer-level burn-in for AI accelerators and co-packaged optical interconnects, underwriting near-term fiscal 2027 revenue expansion toward one hundred forty million dollars. However, trading at fifty-six times trailing sales and over twenty times forward revenue in a five percent Treasury yield regime leaves valuation acutely vulnerable. Semicap history demonstrates that front-loaded tooling buildouts lead to severe capacity digestion cycles once initial test lines are equipped.

Key insights

  • Razor-and-blade contactor consumables buffer gross margins above forty percent, yet cannot fully offset multi-quarter equipment shipment voids between customer tape-outs.
  • Prior at-the-market offerings fortified liquidity above one hundred sixteen million dollars, but structural share dilution permanently constrains per-share owner earnings growth.
  • Incumbent automated test equipment conglomerates developing integrated optical probing cells represent an encroaching competitive threat that caps long-term economic rent extraction.

Deep Dive

The prevailing market narrative treats the company as an indispensable monopoly bottleneck on artificial intelligence hardware reliability. Anchored to a record hundred-million-dollar backlog and guided triple-digit revenue growth, public momentum assumes wafer-level burn-in is permanently mandatory for all frontier processors and optical transceivers. Investors blithely pay fifty-six times trailing sales, assuming uninterrupted software-like recurring compounding.